Impact of preanalytical factors on liquid biopsy in the canine cancer model
Megquier, K.; Husted, C.; Rhoades, J.; White, M. E.; Genereux, D. P.; Chen, F. L.; Xiong, K.; Kwon, E.; Swofford, R.; Painter, C.; Adalsteinsson, V.; London, C. A.; Gardner, H. L.; Karlsson, E. K.
Show abstract
While liquid biopsy has potential to transform cancer diagnostics through minimally-invasive detection and monitoring of tumors, the impact of preanalytical factors such as the timing and anatomical location of blood draw is not well understood. To address this gap, we leveraged pet dogs with spontaneous cancer as a model system, as their compressed disease timeline facilitates rapid diagnostic benchmarking. Key liquid biopsy metrics from dogs were consistent with existing reports from human patients. The tumor content of samples was higher from venipuncture sites closer to the tumor and from a central vein. Metrics also differed between lymphoma and non-hematopoietic cancers, urging cancer-type-specific interpretation. Liquid biopsy was highly sensitive to disease status, with changes identified soon after post chemotherapy administration, and trends of increased tumor fraction and other metrics observed prior to clinical relapse in dogs with lymphoma or osteosarcoma. These data support the utility of pet dogs with cancer as a relevant system for advancing liquid biopsy platforms.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.